NAVEE TECH Launches the Electric Scooter N40 in the Global Market
Recently NAVEE Tech launched NAVEE N40 E-scooter which is exactly the kind of low-cost yet high-value electric scooters designed to help get more commuters onto two wheels. The new electric scooter offers comfortable, enjoyable, and joyful rides.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220628006211/en/
(Photo: Business Wire)
The N40 comes equipped with high-capacity batteries providing impressive range capabilities which can run for nearly 40km without a charge. The 10-inch pneumatic tires, with superior shock absorption, make your ride smoother and more stable even on bumpy terrain or rough surfaces.
With 350watt Brushless Motor, N40’s output helping you conquer up to a 20% grade slope, and supports three different speed level. The maximum speed of N40 can reach 30 km/h. (Noted: The Brushless Motor of Nordic version is 250watt and the maximum speed can reach 20 km/h according to the laws and regulations). N40 is perfect for Nordic commuters.
What’s more, the Smart Battery Management system ensures battery safety and to notify you of any battery alerts when needed. The carefully tuned Dual Braking System utilize the advantage of disc braking and electric brake. With the quick folding system, the N40 can be easily folded almost in 3 seconds to store in the trunk.
The highlighted features of N40 are as below:
• Long range up to 40 km
• 18% superb uphill climbing ability
• 10 inch pneumatic tires
• Rated power 250watt brushless motor
• Max loading weight 100kg
• 15cm wide deck
• Front E-ABS brake with rear disc brake
• Three speed levels
• Support cruise control & energy recovery
• Ultra-bright front light
NAVEE TECH has a professional design and R&D team with rich experience in micro-mobility. The design and development of each product is based on the thorough understanding of customers’ requirements and pain points, as well as the full consideration of practicality, safety comfort at the stage of design and performance value.
In middle July, NAVEE N40 will be available at global market with only priced at €569.
About NAVEE TECH
NAVEE TECH, founded in 2020, is an innovative company specializing in the R&D, production, and distribution of e-scooters and e-bikes. NAVEE is committed to providing vehicles featuring the latest innovations & technology to global customers, and to making micro-mobility more smart, enjoyable, and convenient.
For more information, please visit http://naveetech.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220628006211/en/
Contact information
NAVEE TECH
Natalie Zhang
marketing@navee.tech; sales@navee.tech; service@navee.tech
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stafford Establishes Timberland Continuation Fund at USD 1.2 billion4.12.2025 11:53:00 EET | Press release
Stafford Capital Partners (“Stafford”) today announced it has established a USD 1.2 billion continuation vehicle, the Stafford International Timberland Continuation Fund (The Continuation Fund or The Fund), marking a significant milestone in the firm’s strategic management of its timberland holdings. The Continuation Fund is a "roll-up" of three of Stafford’s existing core timberland funds – Stafford International Timberland funds VI, VII and VIII – into a new perpetual fund that will hold 74 high-quality core timberland assets. The fully-deployed portfolio took Stafford seven years to construct and holds interests in over 6.3m acres of commercial timberland in the USA, New Zealand, Australia and Latin America. This includes a number of assets that are seen as key strategic holdings in these regions where high-quality assets can be tightly held. The Fund holds positions in the 2nd and 3rd largest commercial timberlands estates in New Zealand, one of Australia’s largest softwood forest
Smartstream Introduces Agentic AI ‘Smart Agents’ for Investigations and Exceptions Handling4.12.2025 10:55:00 EET | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces the preview of Smart Agents for Investigations, a breakthrough in financial operations that brings augmented and autonomous exception handling to reconciliations and back-office processes. The new investigation agent combines domain-trained AI agents, workflow adoption, and embedded controls to triage, investigate, resolve, and learn from exceptions - reducing manual effort, accelerating time to resolution, and strengthening auditability. It will add a layer of intelligence on top of Smartstream’s current reconciliations and exceptions solutions. It understands the breaks context, adheres to customer playbooks and reaches out for missing information. It documents every step for audit and compliance, allowing analysts to focus on risk. Finally, it augments the analyst’s investigation with contextual information radically changing the user experience to review and a
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes4.12.2025 10:00:00 EET | Press release
LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with Sanofi. This collaboration combines LabGenius’ AI/ML-driven antibody design capabilities with Sanofi’s expertise in the development of therapeutic NANOBODY® molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA™ platform to optimise NANOBODY® molecules for multiple new targets in the area of inflammation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204759388/en/ “We are truly excited about this new collaboration with Sanofi,”said LabGenius’ CSO, Dr. Angus Sinclair. “This partnership serves as strong validation of our platform’s unique ability to tackle complex antibody co-optimisation challenges across
GoWit One: The Unified AI Operating System Set to Revolutionize Commerce & Retail Media4.12.2025 08:09:00 EET | Press release
GoWit, a global AdTech leader in omnichannel Commerce and Retail Media, announced the launch of GoWit One, the unified AI operating system that brings automation, unification, and real-time intelligence into a single ad platform for agencies operating across multiple retailers, channels, and markets. By bringing these three elements into one dashboard, GoWit One addresses the industry's most critical bottleneck: operational inefficiency. The platform enables agencies to manage campaigns across multiple retailers, channels, and markets, reducing manual AdOps workflows by 98%, turning a process that used to take hours into as little as 10 minutes. Solving the “Fragmentation Crisis” Despite the explosive growth of Retail Media, the industry faces a significant hurdle. According to the IAB, 70% of the market still lacks end-to-end AI adoption. Media buyers are currently forced to juggle disconnected networks, compliance rules, and dashboards, leading to manual errors and an inability to sc
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings4.12.2025 08:00:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook. The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. S&P notes the company’s well-established brand portfolio, global footprint, including an expanding presence in emerging markets, and continued investment in science-based innovation. S&P highlights momentum from recent launches, including Nemluvio® (nemolizumab), alongside improving profitability and expanding free operating cash flow. The agency also notes Galderma’s disciplined financial policy, supporting expectations of continued deleveraging over the coming years. The positive outlook indicates that an upgrade could be considered over the next 12–24 months subject to Galderma continuing to deliver profitable g
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom